Cite
APA Citation
Wright, A. P., Fontana, R. J., & Stidham, R. W. (n.d.). vedolizumab is safe and effective in moderate‐to‐severe inflammatory bowel disease following liver transplantation. Liver transplantation, 23(7), 968–971. http://access.bl.uk/ark:/81055/vdc_100047471628.0x000013